Novo Holdings skruer op for investeringerne i life science

Efter en række succesfulde investeringer melder Novo Holdings om øget lyst til at skyde penge i life science-selskaber. "Life science-sektoren ligger i vores DNA," siger adm. direktør Kasim Kutay.

Kasim Kutay, adm. direktør i Novo Holdings. | Photo: Kenneth Koustrup Lysbjerg/Finans

Novo Holdings skruer op for investeringerne i life science- industrien og vil i de kommende år også sin eksponering mod industrien.

Det siger adm. direktør Kasim Kutay til MedWatch i kølvandet på offentliggørelsen af holdingselskabets regnskab for 2017, der viste et overskud på 19,1 mia. kr og nye investeringer i life science-industrien for samlet 13,9 mia. kr.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from AMWatch

Savills IM working hard on first Nordic residential investment

The global property investor has plans to expand its growing portfolio in Denmark with a new asset class, residential real estate, "very soon," says Head of Nordics Peter Broström. The manager still believes in the office and retail sectors, despite the pandemic and rising inflation.

Latest news


Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch